Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026)
Enanta Pharmaceuticals (ENTA) reported Tax Rate of 0.05% for Q1 2026, down 550.0% on a YoY basis from 0.01% in Q1 2025, and up 73.44% quarter-over-quarter from 0.2% in Q4 2025.
Enanta Pharmaceuticals (ENTA) Tax Rate (2014 - 2026) Analysis & Trends
Enanta Pharmaceuticals has reported Tax Rate for 13 years, with the latest figure at 0.05% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate fell 550.0% year-over-year to 0.05%; the trailing twelve-month figure through Mar 2026 stood at 0.15% (down 285.0% YoY), and the FY2025 full-year result was 1.99%, up 34.0% from the prior year.
- Tax Rate for Q1 2026 stood at 0.05%, up from 0.2% in the prior quarter.
- The five-year high for Tax Rate was 5.45% in Q1 2025, with the low at 12.11% in Q2 2023.
- Historically, Tax Rate has averaged 0.46% across 5 years, with a median of 0.63% in 2022.
- The largest YoY upside for Tax Rate was 14521 bps in 2022 against a maximum downside of 2670 bps in 2022.
- Enanta Pharmaceuticals' Tax Rate stood at 0.12% in 2022, then surged by 1460 bps to 1.83% in 2023, then gained by 0 bps to 1.83% in 2024, then sank by 111 bps to 0.2% in 2025, then surged by 73 bps to 0.05% in 2026.
- The last three Tax Rate figures came in at 0.05% (Q1 2026), 0.2% (Q4 2025), and 0.17% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Enanta Pharmaceuticals | 365.48 Mn | 201.71 Mn | - | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05% |
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | -0.20% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | -0.17% |
| Sep 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.16% |
| Mar 31, 2025 | 5.45% |
| Mar 31, 2025 | 5.45% |
| Dec 31, 2024 | 1.83% |
| Dec 31, 2024 | 1.83% |
| Sep 30, 2024 | 1.91% |
| Sep 30, 2024 | 1.91% |
| Jun 30, 2024 | 1.71% |
| Jun 30, 2024 | 1.71% |
| Mar 31, 2024 | 1.15% |
| Mar 31, 2024 | 1.15% |
| Dec 31, 2023 | 1.83% |
| Dec 31, 2023 | 1.83% |